163 related articles for article (PubMed ID: 30410595)
21. The Landscape of Iron Metabolism-Related and Methylated Genes in the Prognosis Prediction of Clear Cell Renal Cell Carcinoma.
Mou Y; Zhang Y; Wu J; Hu B; Zhang C; Duan C; Li B
Front Oncol; 2020; 10():788. PubMed ID: 32528886
[No Abstract] [Full Text] [Related]
22. Bioinformatic identification of key genes and analysis of prognostic values in clear cell renal cell carcinoma.
Luo T; Chen X; Zeng S; Guan B; Hu B; Meng Y; Liu F; Wong T; Lu Y; Yun C; Hocher B; Yin L
Oncol Lett; 2018 Aug; 16(2):1747-1757. PubMed ID: 30008862
[TBL] [Abstract][Full Text] [Related]
23. Gene expression analysis in clear cell renal cell carcinoma using gene set enrichment analysis for biostatistical management.
Maruschke M; Reuter D; Koczan D; Hakenberg OW; Thiesen HJ
BJU Int; 2011 Jul; 108(2 Pt 2):E29-35. PubMed ID: 21435154
[TBL] [Abstract][Full Text] [Related]
24. Long Non-Coding RNA LUCAT1 Promotes Proliferation and Invasion in Clear Cell Renal Cell Carcinoma Through AKT/GSK-3β Signaling Pathway.
Zheng Z; Zhao F; Zhu D; Han J; Chen H; Cai Y; Chen Z; Xie W
Cell Physiol Biochem; 2018; 48(3):891-904. PubMed ID: 30032137
[TBL] [Abstract][Full Text] [Related]
25. MCM2-7 in Clear Cell Renal Cell Carcinoma: MCM7 Promotes Tumor Cell Proliferation.
Zhang J; Zhang H; Wang Y; Wang Q
Front Oncol; 2021; 11():782755. PubMed ID: 34993142
[TBL] [Abstract][Full Text] [Related]
26. Identification of the Potential Prognosis Biomarkers in Hepatocellular Carcinoma: An Analysis Based on WGCNA and PPI.
Huang J; Zhan Y; Jiang L; Gao Y; Zhao B; Zhang Y; Zhang W; Zheng J; Yu J
Int J Gen Med; 2021; 14():9555-9565. PubMed ID: 34916837
[TBL] [Abstract][Full Text] [Related]
27. A
Ye M; He Z; Dai W; Li Z; Chen X; Liu J
Oncol Lett; 2018 Oct; 16(4):4169-4178. PubMed ID: 30214555
[TBL] [Abstract][Full Text] [Related]
28. Identification of UBE2I as a Novel Biomarker in ccRCC Based on a Large-Scale CRISPR-Cas9 Screening Database and Immunohistochemistry.
Li F; Lai L; You Z; Cheng H; Guo G; Tang C; Xu L; Liu H; Zhong W; Lin Y; Wang Q; Lin Y; Wei Y
Front Mol Biosci; 2022; 9():813428. PubMed ID: 35211510
[No Abstract] [Full Text] [Related]
29. A novel correlation between ATP5A1 gene expression and progression of human clear cell renal cell carcinoma identified by co‑expression analysis.
Yuan L; Chen L; Qian K; Wang G; Lu M; Qian G; Cao X; Jiang W; Xiao Y; Wang X
Oncol Rep; 2018 Feb; 39(2):525-536. PubMed ID: 29207195
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic and prognostic value of CEP55 in clear cell renal cell carcinoma as determined by bioinformatics analysis.
Zhou L; Liu S; Li X; Yin M; Li S; Long H
Mol Med Rep; 2019 May; 19(5):3485-3496. PubMed ID: 30896867
[TBL] [Abstract][Full Text] [Related]
31. Identification of potential crucial genes associated with carcinogenesis of clear cell renal cell carcinoma.
Song E; Song W; Ren M; Xing L; Ni W; Li Y; Gong M; Zhao M; Ma X; Zhang X; An R
J Cell Biochem; 2018 Jul; 119(7):5163-5174. PubMed ID: 29227586
[TBL] [Abstract][Full Text] [Related]
32. Bioinformatics and functional analyses of key genes and pathways in human clear cell renal cell carcinoma.
Wang J; Yuan L; Liu X; Wang G; Zhu Y; Qian K; Xiao Y; Wang X
Oncol Lett; 2018 Jun; 15(6):9133-9141. PubMed ID: 29805645
[TBL] [Abstract][Full Text] [Related]
33. Co-expression Network Analysis of Biomarkers for Adrenocortical Carcinoma.
Yuan L; Qian G; Chen L; Wu CL; Dan HC; Xiao Y; Wang X
Front Genet; 2018; 9():328. PubMed ID: 30158955
[TBL] [Abstract][Full Text] [Related]
34. The screening of pivotal gene expression signatures and biomarkers in renal carcinoma.
Ruan H; Li S; Tong J; Cao Q; Song Z; Wang K; Huang Y; Bao L; Chen X; Yang H; Chen K; Zhang X
J Cancer; 2019; 10(25):6384-6394. PubMed ID: 31772671
[TBL] [Abstract][Full Text] [Related]
35. TOP2A Promotes Tumorigenesis of High-grade Serous Ovarian Cancer by Regulating the TGF-β/Smad Pathway.
Gao Y; Zhao H; Ren M; Chen Q; Li J; Li Z; Yin C; Yue W
J Cancer; 2020; 11(14):4181-4192. PubMed ID: 32368301
[No Abstract] [Full Text] [Related]
36. Weighted gene co-expression network analysis identified MYL9 and CNN1 are associated with recurrence in colorectal cancer.
Qiu X; Cheng SH; Xu F; Yin JW; Wang LY; Zhang XY
J Cancer; 2020; 11(8):2348-2359. PubMed ID: 32127961
[TBL] [Abstract][Full Text] [Related]
37. Comprehensive investigation of key biomarkers and pathways in hepatitis B virus-related hepatocellular carcinoma.
Liao X; Yu T; Yang C; Huang K; Wang X; Han C; Huang R; Liu X; Yu L; Zhu G; Su H; Qin W; Deng J; Zeng X; Han B; Han Q; Liu Z; Zhou X; Liu J; Gong Y; Liu Z; Huang J; Lu L; Ye X; Peng T
J Cancer; 2019; 10(23):5689-5704. PubMed ID: 31737106
[No Abstract] [Full Text] [Related]
38. Integrated bioinformatics analysis for the identification of potential key genes affecting the pathogenesis of clear cell renal cell carcinoma.
Cui H; Xu L; Li Z; Hou KZ; Che XF; Liu BF; Liu YP; Qu XJ
Oncol Lett; 2020 Aug; 20(2):1573-1584. PubMed ID: 32724399
[TBL] [Abstract][Full Text] [Related]
39. Downregulation of CLDN7 due to promoter hypermethylation is associated with human clear cell renal cell carcinoma progression and poor prognosis.
Li Y; Gong Y; Ning X; Peng D; Liu L; He S; Gong K; Zhang C; Li X; Zhou L
J Exp Clin Cancer Res; 2018 Nov; 37(1):276. PubMed ID: 30428910
[TBL] [Abstract][Full Text] [Related]
40. Identification of EGFR as a Novel Key Gene in Clear Cell Renal Cell Carcinoma (ccRCC) through Bioinformatics Analysis and Meta-Analysis.
Wang S; Yu ZH; Chai KQ
Biomed Res Int; 2019; 2019():6480865. PubMed ID: 30895194
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
